Peter R Rossing
Impact in
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hormonal Regulation and Hypertension
Papers in
-
- Diabetes Treatment and Management 209
- Hormonal Regulation and Hypertension 85
- Diabetes Management and Research 58
- Nephrology 202
- Chronic Kidney Disease and Diabetes 178
- Co-authors
- Lise Tarnow (115 shared papers)Hans‐Henrik Parving (112 shared papers)Melanie J. Davies (10 shared papers)John B. Buse (11 shared papers)Απόστολος Τσάπας (7 shared papers)Geltrude Mingrone (7 shared papers)Hiddo Lambers Heerspink (109 shared papers)Frederik Persson (121 shared papers)
- Journals
- Diabetes Care (79 papers)Nephrology Dialysis Transplantation (63 papers)Diabetes (52 papers)Kidney International (52 papers)Diabetologia (52 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Peter R Rossing
866 papers receiving 57.3k citations
Peter R Rossing's Hit Papers
Peers
Comparison fields: 5 of 179
- Nephrology 12.8k
- Endocrinology, Diabetes and Metabolism 25.4k
- Cardiology and Cardiovascular Medicine 10.2k
- Clinical Biochemistry 1.8k
- Pharmacology 3.1k
Countries citing papers authored by Peter R Rossing
This map shows the geographic impact of Peter R Rossing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R Rossing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R Rossing more than expected).
Fields of papers citing papers by Peter R Rossing
This network shows the impact of papers produced by Peter R Rossing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R Rossing. The network helps show where Peter R Rossing may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter R Rossing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 917 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dapagliflozin in Patients with Chronic Kidney Disease Hit paper breakdown → | 2020 | 3838 |
| 2 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD Hit paper breakdown → | 2019 | 3184 |
| 3 | Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2018 | 2934 |
| 4 | Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes Hit paper breakdown → | 2020 | 1931 |
| 5 | Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 1216 |
| 6 | Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2018 | 1207 |
| 7 | Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Hit paper breakdown → | 2012 | 1121 |
| 8 | Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Hit paper breakdown → | 2024 | 1075 |
| 9 | 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes Hit paper breakdown → | 2023 | 939 |
| 10 | 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2019 | 923 |
| 11 | Diabetic kidney disease Hit paper breakdown → | 2015 | 909 |
| 12 | KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Hit paper breakdown → | 2022 | 838 |
| 13 | Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis Hit paper breakdown → | 2021 | 810 |
| 14 | Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 664 |
| 15 | A catalog of genetic loci associated with kidney function from analyses of a million individuals Hit paper breakdown → | 2019 | 605 |
| 16 | Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy Hit paper breakdown → | 2015 | 571 |
| 17 | Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Hit paper breakdown → | 2022 | 541 |
| 18 | Diabetes and Hypertension: A Position Statement by the American Diabetes Association Hit paper breakdown → | 2017 | 520 |
| 19 | Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 519 |
| 20 | Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Hit paper breakdown → | 2020 | 417 |
About Peter R Rossing
Peter R Rossing is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Physiology, having authored 917 papers that have together received 59.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (209 papers), Chronic Kidney Disease and Diabetes (178 papers), Hormonal Regulation and Hypertension (85 papers), Blood Pressure and Hypertension Studies (81 papers), Diabetes Management and Research (58 papers), Cardiovascular Function and Risk Factors (47 papers), Pancreatic function and diabetes (42 papers) and Diet and metabolism studies (36 papers). The work is most often cited by research in Nephrology (12.8k citations), Endocrinology, Diabetes and Metabolism (25.4k citations), Cardiology and Cardiovascular Medicine (10.2k citations), Clinical Biochemistry (1.8k citations) and Pharmacology (3.1k citations). Peter R Rossing has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Lise Tarnow, Hans‐Henrik Parving, Melanie J. Davies, John B. Buse, Απόστολος Τσάπας, Geltrude Mingrone, Hiddo Lambers Heerspink, Frederik Persson, Deborah J. Wexler and David A. D’Alessio. Their work appears in journals such as Diabetes Care, Nephrology Dialysis Transplantation, Diabetes, Kidney International and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.